The present application provides bicyclic amines that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
-
Page/Page column 172; 175; 189-190
(2021/04/17)
More Articles about upstream products of 1403332-98-8